Travellers at the mainland Chinese border in Shenzhen. China reopened its borders for international travel on Sunday and will roll out more pro-growth measures to steady the economy. Photo: Dickson Lee
Travellers at the mainland Chinese border in Shenzhen. China reopened its borders for international travel on Sunday and will roll out more pro-growth measures to steady the economy. Photo: Dickson Lee

Citigroup says big pharma preferred by foreign investors as China reopens, appetite for pre-revenue biotech firms wanes

  • Foreign investors are looking for firms with a track record of profit making and direct beneficiaries of China’s reopening, Citi analyst says
  • So-called chapter 18A companies may not benefit much as their financial figures are not solid, Everbright Securities analyst says

Travellers at the mainland Chinese border in Shenzhen. China reopened its borders for international travel on Sunday and will roll out more pro-growth measures to steady the economy. Photo: Dickson Lee
Travellers at the mainland Chinese border in Shenzhen. China reopened its borders for international travel on Sunday and will roll out more pro-growth measures to steady the economy. Photo: Dickson Lee
READ FULL ARTICLE